Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
March 25th, 2019
7.8K views
Ovarian cancer forms metastases throughout the peritoneal cavity. Here, we present a protocol to make and use folate-receptor targeted surface-enhanced resonance Raman scattering nanoprobes that reveal these lesions with high specificity via ratiometric imaging. The nanoprobes are administered intraperitoneally to living mice, and the derived images correlate well with histology.
Overview
This study presents a protocol for using folate-receptor targeted surface-enhanced resonance Raman scattering nanoprobes to image ovarian cancer metastases with high specificity. The method allows for ratiometric imaging of targeted and non-targeted nanoparticles, enhancing the accuracy of tumor detection.
Key Study Components
Area of Science
- Neuroscience
- Oncology
- Nanotechnology
Background
- Ovarian cancer often metastasizes within the peritoneal cavity.
- Current imaging techniques may not effectively detect microscopic tumors.
- Nanoparticles can be used for targeted imaging in malignancies.
- Ratiometric imaging helps reduce false signals in tumor detection.
Purpose of Study
- To develop a protocol for imaging ovarian cancer metastases.
- To utilize folate-receptor targeted nanoprobes for enhanced specificity.
- To improve the accuracy of tumor detection using ratiometric imaging techniques.
Methods Used
- Topical application of nanoparticles for imaging.
- Intraperitoneal or intravenous administration of nanoprobes.
- Ratiometric imaging of targeted and non-targeted nanoparticles.
- Synthesis of gold nanostars for imaging applications.
Main Results
- High specificity in imaging ovarian cancer lesions was achieved.
- Images derived from nanoprobes correlated well with histological findings.
- The method demonstrated effectiveness in detecting microscopic tumors.
- Ratiometric imaging reduced false signals significantly.
Conclusions
- The developed protocol enhances the detection of ovarian cancer metastases.
- Folate-receptor targeted nanoprobes provide a promising imaging technique.
- This method could be applicable to other tumor types as well.
Frequently Asked Questions
What is the main advantage of using ratiometric imaging?
Ratiometric imaging helps to diminish false signals and provides a more accurate representation of tumor extent.
How are the nanoparticles administered?
The nanoparticles can be administered either intraperitoneally or intravenously for high precision imaging.
What type of cancer is primarily focused on in this study?
The study primarily focuses on ovarian cancer and its metastases.
What is the significance of folate-receptor targeting?
Folate-receptor targeting allows for enhanced specificity in imaging cancer cells that overexpress these receptors.
Can this imaging technique be applied to other tumor types?
Yes, the method may be applicable to various tumor types beyond ovarian cancer.
Executive Industry Relevance
This method enables high-specificity detection of microscopic ovarian cancer metastases using folate-receptor targeted SERRS nanoprobes, addressing a critical unmet need in early-stage tumor visualization. By employing a ratiometric imaging approach, the technique reduces false-positive signals from non-specific binding, improving predictive confidence in target engagement. The intraperitoneal delivery route aligns with the peritoneal metastatic pattern of ovarian cancer, supporting translational relevance for intraoperative imaging applications.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of folate receptor overexpression as a therapeutic hypothesis in ovarian cancer models.
- Operational Value: Provides a quantitative, imaging-based readout for target-specific nanoparticle accumulation.
- Predictive Value: Supports mechanistic de-risking by correlating nanoprobe signal with histological confirmation of micrometastases.
Screening & Assay Development
- Scientific Value: Generates distinct, decouplable Raman spectra for targeted and non-targeted nanoprobes, enabling multiplexed detection.
- Operational Value: Yields a ratiometric signal output that normalizes for variability in nanoparticle delivery and tissue background.
- Assay Readiness: Establishes a standardized protocol for nanoprobe synthesis, functionalization, and intraperitoneal administration in preclinical models.
Translational & Preclinical Research
- Translational Continuity: Uses intraperitoneal delivery to model clinical administration during surgical intervention in the peritoneal cavity.
- Disease-Relevant System: Targets folate receptor, which is overexpressed in many ovarian cancers, enhancing relevance to human pathology.
- <Predictive De-risking: Enables visualization of microscopic tumor implants that are otherwise undetectable, informing risk-adjusted advancement decisions.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target validation to preclinical imaging, supporting hypothesis-driven evaluation of folate receptor as a biomarker in ovarian cancer metastasis models.
- Discovery Biology: Facilitates hypothesis testing of folate receptor-mediated targeting in disseminated tumor models.
- Screening: Produces assay-ready nanoprobes with quantifiable, ratiometric outputs for comparing targeting efficiency.
- Analytics: Employs Classical Least Squares fitting to decouple overlapping spectra and generate point-wise ratio images for tumor delineation.
- Translational Research: Bridges in vivo imaging with ex vivo tissue validation, supporting continuity toward clinical intraoperative use.
- Enterprise Reuse: Establishes a modular nanoprobe platform adaptable to other targets via antibody or ligand exchange.
Operational & Enterprise Impact
- Scientific Value: Enhances target validation confidence through specific, ratiometric detection of receptor-positive micrometastases.
- Operational Value: Delivers reproducible nanoparticle synthesis and functionalization protocols with defined QC steps (TEM, DLS, UV-Vis).
- Strategic Value: Reduces biological risk in target selection by providing direct visualization of target engagement in relevant disease models.
- Portfolio Impact: Informs go/no-go decisions by enabling early detection of treatment-resistant microscopic disease.
Implementation Considerations
- Requires expertise in nanoparticle synthesis, surface chemistry, and Raman spectroscopy.
- Depends on access to a Raman microphotospectrometer with motorized stage and appropriate laser excitation.
- Necessitates standardization across teams for nanoprobe injection, peritoneal washing, and imaging protocol execution.
- Adaptation to other model systems may require optimization of nanoprobe dose and incubation time.
- Current limitation: lack of a commercial wide-field Raman imaging system restricts real-time intraoperative application.
Biopharma FAQs
Why does ratiometric imaging improve target validation confidence?
Ratiometric imaging divides the signal of folate-targeted nanoprobes by that of non-targeted controls, canceling out non-specific binding and background fluorescence. This yields a specific signal proportional to receptor-mediated uptake, enhancing confidence in target engagement measurements.
How does intraperitoneal administration support discovery pipeline integration?
Intraperitoneal delivery mirrors the natural metastatic spread of ovarian cancer in the peritoneal cavity, enabling physiologically relevant modeling of micrometastasis detection. This route ensures nanoparticle exposure to disseminated tumor implants without systemic distribution, supporting discovery-stage target validation in clinically relevant contexts.
What quantitative measurements enable folate receptor-specific detection?
The method generates point-wise ratios of Classical Least Squares scores from targeted versus non-targeted nanoprobe reference spectra. These ratios provide a quantitative, spatially resolved readout of folate receptor-mediated nanoprobe accumulation, enabling detection of microscopic tumor implants.
Why are replication requirements important for cross-functional collaboration?
Replication ensures consistent nanoprobe synthesis, functionalization, and imaging results across experiments, which is essential for reliable data sharing between chemistry, biology, and imaging teams. Standardized protocols with defined QC steps (e.g., centrifugation washes, dialysis) support reproducibility and collaborative workflow integration.
What statistical analysis is required before implementing this imaging approach?
Classical Least Squares fitting is required to decouple the overlapping Raman spectra of the two nanoprobe flavors and extract their individual signal contributions. This analysis enables the calculation of ratiometric values that distinguish specific targeting from non-specific background, forming the basis for quantitative tumor detection.
